{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:40:40Z","timestamp":1792453240390,"version":"4.5.0"},"reference-count":43,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glaucoma is the foremost cause of irreversible blindness, and more than 50% of cases remain undiagnosed. Our objective was to report the costs of a glaucoma detection programme operationalised through Philadelphia community centres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The analysis was performed using a healthcare system perspective in 2013 US dollars. Costs of examination and educational workshops were captured. Measures were total programme costs, cost\/case of glaucoma detected and cost\/case of any ocular disease detected (including glaucoma). Diagnoses are reported at the individual level (therefore representing a diagnosis made in one or both eyes). Staff time was captured during site visits to 15 of 43 sites and included time to deliver examinations and workshops, supervision, training and travel. Staff time was converted to costs by applying wage and fringe benefit costs from the US Bureau of Labor Statistics. Non-staff costs (equipment and mileage) were collected using study logs. Participants with previously diagnosed glaucoma were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>1649 participants were examined. Mean total per-participant examination time was 56 min (SD 4). Mean total examination cost\/participant was $139. The cost\/case of glaucoma newly identified (open-angle glaucoma, angle-closure glaucoma, glaucoma suspect, or primary angle closure) was $420 and cost\/case for any ocular disease identified was $273.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Glaucoma examinations delivered through this programme provided significant health benefit to hard-to-reach communities. On a per-person basis, examinations were fairly low cost, though opportunities exist to improve efficiency. Findings serve as an important benchmark for planning future community-based glaucoma examination programmes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjophthalmol-2016-310078","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T20:40:17Z","timestamp":1498596017000},"page":"225-232","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Costs of a community-based glaucoma detection programme: analysis of the Philadelphia Glaucoma Detection and Treatment Project"],"prefix":"10.1136","volume":"102","author":[{"given":"Laura T","family":"Pizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Waisbourd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harjeet","family":"Sembhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E","family":"Crews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinan B","family":"Saaddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deon","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Jay","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,6,27]]},"reference":[{"key":"2020050713003280000_102.2.225.1","unstructured":"Vision problems in the U.S.: prevalence of Adult Vision impairment and Age-Related disease in America. Vision problems U.S. web site. http:\/\/www.visionproblemsus.org. Updated 2012. (accessed 8 Apr 2014)."},{"key":"2020050713003280000_102.2.225.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013"},{"key":"2020050713003280000_102.2.225.3","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.081224"},{"key":"2020050713003280000_102.2.225.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.06.004"},{"key":"2020050713003280000_102.2.225.5","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0866"},{"key":"2020050713003280000_102.2.225.6","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.532"},{"key":"2020050713003280000_102.2.225.7","unstructured":"Prevention of Blindness and Visual impairment. World Health Organization web site. http:\/\/www.who.int\/blindness\/causes\/priority\/en\/index7.html. Updated 2014. (accessed 8 Apr 2014)."},{"key":"2020050713003280000_102.2.225.8","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.1.12"},{"key":"2020050713003280000_102.2.225.9","unstructured":"Cost of Vision problems: the economic burden of Vision loss and Eye Disorders in the United States. Prevent Blindness America Web site. http:\/\/www.preventblindness.org\/sites\/default\/files\/national\/documents\/Economic_Burden_of_Vision_Final_Report_130611.pdf (accessed 14 Jan 2016)."},{"key":"2020050713003280000_102.2.225.10","unstructured":"Final Recommendation Statement. Glaucoma: screening. U.S. Preventive Services Task Force. 2015. http:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementFinal\/glaucoma-screening."},{"key":"2020050713003280000_102.2.225.11","doi-asserted-by":"publisher","DOI":"10.1001\/archopthalmol.2011.1224"},{"key":"2020050713003280000_102.2.225.12","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32832401a9"},{"key":"2020050713003280000_102.2.225.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16257-0"},{"key":"2020050713003280000_102.2.225.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111143252004"},{"key":"2020050713003280000_102.2.225.15","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-199604000-00016"},{"key":"2020050713003280000_102.2.225.16","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.11.1625"},{"key":"2020050713003280000_102.2.225.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.01.025"},{"key":"2020050713003280000_102.2.225.18","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-5126"},{"key":"2020050713003280000_102.2.225.19","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.12.1819"},{"key":"2020050713003280000_102.2.225.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.12.056"},{"key":"2020050713003280000_102.2.225.21","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.2727"},{"key":"2020050713003280000_102.2.225.22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-11549"},{"key":"2020050713003280000_102.2.225.23","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200725040-00003"},{"key":"2020050713003280000_102.2.225.24","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.12.1754"},{"key":"2020050713003280000_102.2.225.25","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802379996"},{"key":"2020050713003280000_102.2.225.26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/09286586.2015.1099683","article-title":"Improving access to eye care among persons at high-risk for Glaucoma in Philadelphia: design and methodology","volume":"23","author":"Hark","year":"2016","journal-title":"Ophthalmic Epidemiol"},{"key":"2020050713003280000_102.2.225.27","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.ophtha.2016.04.031","article-title":"The Philadelphia Glaucoma detection and treatment project: detection rates and initial management","volume":"123","author":"Waisbourd","year":"2016","journal-title":"Ophthalmology"},{"key":"2020050713003280000_102.2.225.28","unstructured":"May 2013 Metropolitan and Nonmetropolitan Area Occupational Employment and wage estimates, Philadelphia, PA Metropolitan Division. Bureau of Labor Statistics web site. http:\/\/www.bls.gov\/oes\/current\/oes_37964.htm. Updated 2014. (accessed 15 May 2014)."},{"key":"2020050713003280000_102.2.225.29","unstructured":"Grants & Funding. National Institutes of Health: office of Extramural Research web site. http:\/\/grants.nih.gov\/grants\/policy\/salcap_summary.htm. Updated 2015. (accessed 21 Jan 2015)."},{"key":"2020050713003280000_102.2.225.30","unstructured":"Employer costs for employee compensation - March 2014. Bureau of Labor Statistics. U.S. Department of Labor web site. http:\/\/www.bls.gov\/news.release\/archives\/ecec_06112014.pdf Updated 2014. (accessed 15 Sep 2014)."},{"key":"2020050713003280000_102.2.225.31","unstructured":"Revenue Procedure Notice 2012-72. Part III - Administrative, Procedural, and Miscellaneous. Internal Revenue Service website. https:\/\/www.irs.gov\/pub\/irs-drop\/n-12-72.pdf Updated 21 November 2012. (accessed 16 Oct 2015)."},{"key":"2020050713003280000_102.2.225.32","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.1.12"},{"key":"2020050713003280000_102.2.225.33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/jamaophthalmol.2015.5479","article-title":"Self-reported function, Health Resource Use, and Total Health Care costs among Medicare beneficiaries with Glaucoma","volume":"134","author":"Prager","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2020050713003280000_102.2.225.34","doi-asserted-by":"crossref","first-page":"618.e1","DOI":"10.1016\/j.ajo.2005.01.019","article-title":"Effects of changes in self-reported vision on cognitive, affective, and functional status and living arrangements among the elderly","volume":"140","author":"Sloan","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"2020050713003280000_102.2.225.35","doi-asserted-by":"publisher","DOI":"10.1007\/BF03324611"},{"key":"2020050713003280000_102.2.225.36","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32832401a9"},{"key":"2020050713003280000_102.2.225.37","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6264"},{"key":"2020050713003280000_102.2.225.38","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1990.11"},{"key":"2020050713003280000_102.2.225.39","unstructured":"Historical rates. Currency Converter web site. http:\/\/fxtop.com\/en\/historical-exchange-rates.php. Updated 2014. (accessed 10 Oct 2014)."},{"key":"2020050713003280000_102.2.225.40","unstructured":"CPI inflation calculator. Bureau of Labor Statistics web site. http:\/\/www.bls.gov\/data\/inflation_calculator.htm. Updated 2014. (accessed 15 Oct 2014)."},{"key":"2020050713003280000_102.2.225.41","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.6.707"},{"key":"2020050713003280000_102.2.225.42","doi-asserted-by":"publisher","DOI":"10.1016\/0275-5408(95)00065-L"},{"key":"2020050713003280000_102.2.225.43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/oxfordjournals.pubmed.a024673","article-title":"The Bristol Shared Care Glaucoma study--validity of measurements and patient satisfaction","volume":"19","author":"Gray","year":"1997","journal-title":"J Public Health Med"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2016-310078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:54:46Z","timestamp":1601096086000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2016-310078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,27]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,24]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1136\/bjophthalmol-2016-310078"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2016-310078","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,27]]}}}